shutterstock_82806616

ACG, a global supplier of integrated manufacturing solutions for the pharmaceutical and nutraceutical industries, has announced the commencement of operations at its state-of-the-art capsule...

The European Commission (EC) has approved a Type II variation extension of indication for Janssen-Cilag International NV's RYBREVANT (amivantamab), in combination with LAZCLUZE (lazertinib),...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) for NMD Pharma's NMD670, a novel, oral, small molecule inhibitor of...